These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31209308)

  • 1. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses.
    Vieira-Silva S; Sabino J; Valles-Colomer M; Falony G; Kathagen G; Caenepeel C; Cleynen I; van der Merwe S; Vermeire S; Raes J
    Nat Microbiol; 2019 Nov; 4(11):1826-1831. PubMed ID: 31209308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative microbiome profiling links gut community variation to microbial load.
    Vandeputte D; Kathagen G; D'hoe K; Vieira-Silva S; Valles-Colomer M; Sabino J; Wang J; Tito RY; De Commer L; Darzi Y; Vermeire S; Falony G; Raes J
    Nature; 2017 Nov; 551(7681):507-511. PubMed ID: 29143816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective function of sclerosing cholangitis on IBD.
    Bedke T; Stumme F; Tomczak M; Steglich B; Jia R; Bohmann S; Wittek A; Kempski J; Göke E; Böttcher M; Reher D; Franke A; Lennartz M; Clauditz T; Sauter G; Fründt T; Weidemann S; Tiegs G; Schramm C; Gagliani N; Pelczar P; Huber S
    Gut; 2024 Jul; 73(8):1292-1301. PubMed ID: 38839272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
    Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
    Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
    PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.
    Torres J; Palmela C; Brito H; Bao X; Ruiqi H; Moura-Santos P; Pereira da Silva J; Oliveira A; Vieira C; Perez K; Itzkowitz SH; Colombel JF; Humbert L; Rainteau D; Cravo M; Rodrigues CM; Hu J
    United European Gastroenterol J; 2018 Feb; 6(1):112-122. PubMed ID: 29435321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
    Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
    Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis.
    Vieira-Silva S; Falony G; Belda E; Nielsen T; Aron-Wisnewsky J; Chakaroun R; Forslund SK; Assmann K; Valles-Colomer M; Nguyen TTD; Proost S; Prifti E; Tremaroli V; Pons N; Le Chatelier E; Andreelli F; Bastard JP; Coelho LP; Galleron N; Hansen TH; Hulot JS; Lewinter C; Pedersen HK; Quinquis B; Rouault C; Roume H; Salem JE; Søndertoft NB; Touch S; ; Dumas ME; Ehrlich SD; Galan P; Gøtze JP; Hansen T; Holst JJ; Køber L; Letunic I; Nielsen J; Oppert JM; Stumvoll M; Vestergaard H; Zucker JD; Bork P; Pedersen O; Bäckhed F; Clément K; Raes J
    Nature; 2020 May; 581(7808):310-315. PubMed ID: 32433607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.